Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer

被引：0
|
作者：
Kelly, R. [1 ]
Wong, S. S. L. [2 ]
Shapiro, J. [3 ]
Weickhardt, A. J. [4 ]
Parente, P. [5 ]
Azad, A. [6 ]
Uccellini, A. [7 ]
Torres, J. [8 ]
Parnis, F. [9 ]
Kwan, E. [10 ]
Brown, S. [11 ]
Steer, C. [12 ]
Warren, M. [13 ]
Gibbs, P. [14 ]
Anton, A. [1 ]
Tran, B. [1 ]
机构：
[1] Walter Eliza Hall Inst Med Res, Clin Data Clin Trials & Biomarkers, Parkville, Vic, Australia
[2] Sunshine Hosp Western Hlth, Med Affairs Dept, St Albans, Vic, Australia
[3] Alfred Hosp, Med Oncol, Melbourne, Vic, Australia
[4] Olivia Newton John Canc Wellness & Res Ctr, Dept Med Oncol, Heidelberg, Vic, Australia
[5] Box Hill Hosp, Eastern Hlth, Dept Med Oncol, Bldg B, Box Hill, Vic, Australia
[6] Peter MacCallum Canc Ctr, Dept Oncol, Melbourne, Vic, Australia
[7] Austin Hosp, Austin Hlth, Med Oncol, Heidelberg, Vic, Australia
[8] Goulburn Valley Hlth, Dept Med Oncol, Shepparton, Vic, Australia
[9] Adelaide Canc Ctr, Dept Med Oncol, Adelaide, SA, Australia
[10] Monash Canc Ctr, Monash Hlth, Med Oncol, Bentleigh East, Vic, Australia
[11] Ballarat Hlth Serv, Med Oncol, Ballarat Base Hosp, Ballarat, Vic, Australia
[12] Border Med Oncol, Dept Med Oncol, East Albury, Vic, Australia
[13] Bendigo Hlth, Med Oncol, Bendigo, Vic, Australia
[14] WEHI Walter & Eliza Hall Inst Med Res, Dept Oncol, Parkville, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.202
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
165P
引用
收藏
页码：S1498 / S1499
页数：2
相关论文
共 50 条
  • [41] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Brandon Bernard
    Christopher J. Sweeney
    Current Urology Reports, 2015, 16
  • [42] Management of Hormone-Sensitive Metastatic Prostate Cancer
    Agarwal, Neeraj
    Hussain, Maha
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1221 - +
  • [43] Update on Metastatic Hormone-Sensitive Prostate Cancer
    Chi, Kim N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 277 - 280
  • [44] Influence of aggressive-variant prostate cancer (AVPC) features on outcome of metastatic hormone-sensitive prostate cancer (mHSPC) treated by chemohormonal therapy (CHT).
    Koczka, Kim
    Vanhie, James
    Ibrahim, Andrea
    Bukhari, Nedal
    Reaume, M. Neil
    Sehdev, Sandeep R.
    Potvin, Kylea R.
    Sax, Lori
    Ernst, D. Scott
    Vickers, Michael M.
    Canil, Christina M.
    Winquist, Eric
    Ong, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [45] Real-world outcomes in patients receiving upfront docetaxel chemotherapy for metastatic castrate sensitive prostate cancer
    Wong, Jeff
    Nindra, Udit
    Balakrishnar, Bavanthi
    Della-Fiorentina, Stephen
    Adams, Diana
    Roncolato, Felicia
    Pal, Abhijit
    Chua, Wei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 102 - 102
  • [46] Real-world treatment patterns in metastatic hormone-sensitive prostate cancer (mHSPC) patients in the US, Germany, France, China and Japan
    Goebell, P. J.
    Shah, R.
    Raina, R.
    Rege, S.
    Chen, S. L.
    Lee, V. E.
    Waldeck, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S660 - S661
  • [47] Apalutamide toxicity and tolerability: A real-world multicentre experience in metastatic hormone-sensitive prostate cancer (MHSPC) in the United Kingdom (UK).
    Ramamurthy, Sindhu
    Elumalai, Thiraviyam
    Pearson, Rachel
    Bolnykh, Iakov
    Muhammad-Afzal, Tehreem
    Olukiran, Gbenro
    Arora, Ananya
    Bradley, Gay
    Taft, Kate
    Myint, Nayan Lin
    Htike, Ei The
    Ince, Will
    Jiang, Xue Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [48] Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy
    Wenzel, Mike
    Garcia, Cristina C. C.
    Hoeh, Benedikt
    Jorias, Charlotte
    Humke, Clara
    Koll, Florestan
    Tselis, Nikolaos
    Roedel, Claus
    Graefen, Markus
    Tilki, Derya
    Chun, Felix K. H.
    Mandel, Philipp
    PROSTATE, 2023, 83 (14): : 1365 - 1372
  • [49] Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?
    Davis, Ian D.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [50] Real-World Treatment Patterns and Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: Insights From a Retrospective Cohort Study
    Tashkandi, Emad
    CANCER MANAGEMENT AND RESEARCH, 2025, 17 : 419 - 428
12345